Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term



Rating:

Share or cite this content

Citations should be made in the following way:
M. Raad (Beirut, Lebanon), H. Eid (Beirut, Lebanon), R. Ibrahim (Beirut, Lebanon), A. Kik (Beirut, Lebanon), R. Haouchan (Beirut, Lebanon), N. Nassim (Beirut, Lebanon), K. Hoyek (Beirut, Lebanon), G. Khayat (Beirut, Lebanon), F. Haddad (Beirut, Lebanon), G. Sleilaty (Beirut, Lebanon), M. Riachy (Beirut, Lebanon), m. raad (Beyrouth, Lebanon). Late Breaking Abstract - The revival of lactate dehydrogenase (LDH) in predicting the severity of lung involvement and pneumomediastinum in hospitalized Covid-19. 479

Member's Comments

No comment yet.

Related content which might interest you: Lactate dehydrogenase as a biomarker of advanced disease in idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Correlation between lactate dehydrogenase and therapeutic strategy in Covid-19 pneumonia Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Lactate dehydrogenase isoenzymes in patients with acute exacerbation of chronic obstructive pulmonary disease: An exploratory cross-sectional study Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Diagnostic value of lactate dehydrogenase (LDH) pleural fluid (PF)/serum (S) ratio in the differential diagnosis of pleural exudates Source: Eur Respir J 2002; 20: Suppl. 38, 441s Year: 2002 Increased serum lactate dehydrogenase, a reduced functional exercise capacity and increased MRC dyspnea grade in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 174s Year: 2006 Late Breaking Abstract - Elevated growth differentiation factor 15 in serum correlated with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020 Late Breaking Abstract - Increased risk of pulmonary embolism in patients with radiological severe COVID-19 pneumonia Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Higher serum lactic deydrogenase (LDH) levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure (CPAP) Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Late Breaking Abstract - Physical activity recovery in patients with COVID-19 infection included in pulmonary rehabilitation Source: Virtual Congress 2021 – COVID-19: insights from respiratory physiotherapists Year: 2021 Late Breaking Abstract - Impact of increasing notification thresholds for remote respiratory monitoring in patients with chronic lung disease Source: Virtual Congress 2021 – E-health for COVID-19 Year: 2021 Late Breaking Abstract - Pulmonary embolism in patients admitted by COVID-19. Incidence and features. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Lactate dehydrogenase as a biomarker in brochoalveolar lavage of patients with lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 939-945 Year: 2001 Late Breaking Abstract - Usefulness of lung ultrasound in the diagnosis and early detection of acute chest syndrome in children with sickle cell disease Source: Virtual Congress 2021 – Thoracic ultrasound as a bedside clinical tool Year: 2021 Late Breaking Abstract - Clinical utility of basophil activating test (BAT) in subjects with drug-induced lung disease. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018